Cancer News and Research

Latest Cancer News and Research

Locus Pharmaceuticals enters into discovery research collaboration with Novartis

Locus Pharmaceuticals announced today that it has entered into a discovery research collaboration with Novartis. Locus will collaborate with Novartis to discover novel chemotypes on targets of interest to Novartis’ select therapeutic areas.

12 Oct 2009

Researchers find SNARE-like protein system to help bacteria avoid cell destruction

Infectious diseases currently cause about one-third of all human deaths worldwide, more than all forms of cancer combined. Advances in cell biology and microbial genetics have greatly enhanced understanding of the cause and mechanisms of infectious diseases.

12 Oct 2009

Women who take fertility drugs are at greater risk to develop thyroid cancer

Women who take the most common fertility drugs, progesterone and clomiphene, are at a greater risk to develop thyroid cancer than those who don't, according to a study by the Institute of Cancer Epidemiology, Danish Cancer Society.

12 Oct 2009

Women with deleterious gene mutation diagnosed with breast cancer earlier than their previous generation

Women with a deleterious gene mutation are diagnosed with breast cancer six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas M. D. Anderson Cancer Center.

12 Oct 2009

Canary Foundation to implement biosensor technologies for early cancer detection

Canary Foundation has committed to being the first organization to implement the breakthrough in biosensor technologies in its research pipeline. The new technology promises to revolutionize the early detection cancer field.

12 Oct 2009

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

Researchers at Adaptimmune Limited and the University of Pennsylvania School of Medicine, have announced the approval of an Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) and opening for enrolment of the first ever study using patients’ cells carrying an engineered T cell receptor to treat HIV (SL9 HA-GAG-TCR). The trial may have important implications in the development of new treatments for HIV potentially slowing – or even preventing – the onset of AIDS.

11 Oct 2009

Anti-smoking campaigner Konrad Jamrozik receives the Nigel Gray Award for Achievement in Tobacco Control

An international award has today been given to the University of Adelaide's Professor Konrad Jamrozik, who has spent the past 30 years campaigning against smoking and helping smokers to kick the habit.

9 Oct 2009

The 'Turbocharged' health IT industry

Allscripts, the Chicago-based electronic medical records company, has more than doubled its profits since last year, Forbes reports in a special report. Its stock doubled, too, and it attracted nearly 50 percent more business. It's been a "sweet year" for Glen Tullman, the company's chief. That's due in part to a $19 billion infusion into the health information technology industry from the federal stimulus package.

9 Oct 2009

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

9 Oct 2009

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Health Discovery Corporation, is pleased to announce that it has retained The Dilenschneider Group, headquartered in New York City, to manage the Company’s investor and media relations work. With offices in New York, Washington, DC and Chicago, the Dilenschneider Group provides its clients with some of the finest and most seasoned communications professionals in the world.

9 Oct 2009

Art's Way Scientific to build a 6,000 sq. ft. complex for prestigious cancer research center

Art's Way Manufacturing, Inc., announces its wholly owned subsidiary, Art's Way Scientific, Inc. buildingsforscience.com will be providing design, manufacturing and installation of a 6,000 sq. ft. two story laboratory and office building for Lockard Construction, Inc. www.lockardonline.com who is the prime contractor on this complex for a well known, nationally respected cancer research center. The contract is valued at approximately $3 million.

9 Oct 2009

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreatic enzyme replacement therapy (PERT) in the United States, significantly improves a key measure of fat absorption in patients with CF who suffer from exocrine pancreatic insufficiency (EPI).

9 Oct 2009

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.

9 Oct 2009

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.

9 Oct 2009

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

OncoGenex Pharmaceuticals, Inc., announced today that Scott Cormack, president and chief executive officer of OncoGenex, has been named Canada's Pacific Ernst & Young's Entrepreneur Of The Year(R). The Ernst & Young Entrepreneur Of The Year(R) Award is a high profile business award recognizing entrepreneurs that are building successful, dynamic businesses.

9 Oct 2009

Hepatitis A to be included in Expanded Programme on Immunization in 2010

HTDS www.htdsmedical.com (HTDS) - The issuer's China based operating subsidiary Mellow Hope www.mellowhope.com is pleased to announce the clinical protocol is in the process of being approved. It is known that the Hepatitis A will be included in the Expanded Programme on Immunization (EPI) in 2010.

9 Oct 2009

SCAA to host Survivor Celebration event to mark SCA Awareness Month

A nationwide gathering of sudden cardiac arrest (SCA) survivors will mark SCA Awareness Month with a Survivor Celebration on Friday, October 9th at 7 p.m. in Chicago. This survivor event, hosted by the Sudden Cardiac Arrest Association (SCAA) at the Hyatt Regency O’Hare, 9300 Bryn Mawr Avenue in Rosemont, is part of three-day program that will make up the organization’s annual meeting.

9 Oct 2009

Stein Mart to donate $100,000 to support Susan G. Komen for the Cure

In recognition of National Breast Cancer Awareness Month, Stein Mart is supporting Susan G. Komen for the Cure's promise to save lives and end breast cancer forever by donating one percent of total store sales nationwide from October 16-18, 2009 to Susan G. Komen for the Cure, with a guaranteed minimum donation of $100,000.

9 Oct 2009

Magnetic resonance imaging to help diagnose hidden prostate cancer

Clinical researchers at Princess Margaret Hospital (PMH) can now answer the question that baffles many clinicians - why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer?

9 Oct 2009

Breast cancer misinformation prevalent among U.S. young women; promotes unnecessary fears

Breast cancer has shifted from a taboo subject to one that is discussed freely in the media and in our daily lives.

9 Oct 2009

Cancer News and Research

Latest Cancer News and Research

Locus Pharmaceuticals enters into discovery research collaboration with Novartis

Researchers find SNARE-like protein system to help bacteria avoid cell destruction

Women who take fertility drugs are at greater risk to develop thyroid cancer

Women with deleterious gene mutation diagnosed with breast cancer earlier than their previous generation

Canary Foundation to implement biosensor technologies for early cancer detection

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

Anti-smoking campaigner Konrad Jamrozik receives the Nigel Gray Award for Achievement in Tobacco Control

The 'Turbocharged' health IT industry

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Art's Way Scientific to build a 6,000 sq. ft. complex for prestigious cancer research center

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

Hepatitis A to be included in Expanded Programme on Immunization in 2010

SCAA to host Survivor Celebration event to mark SCA Awareness Month

Stein Mart to donate $100,000 to support Susan G. Komen for the Cure

Magnetic resonance imaging to help diagnose hidden prostate cancer

Breast cancer misinformation prevalent among U.S. young women; promotes unnecessary fears

Cancer Research - Second Edition eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in